Capricor Therapeutics Stock (NASDAQ: CAPR) stock price, news, charts, stock research, profile.
You can purchase shares of Capricor Therapeutics (NASDAQ:CAPR) through any online brokerage.
Other companies in Capricor Therapeutics’s space includes: Tectonic Therapeutic (NASDAQ:TECX), Immunome (NASDAQ:IMNM), Humacyte (NASDAQ:HUMA), Altimmune (NASDAQ:ALT) and Pharming (NASDAQ:PHAR).
Capricor Therapeutics has a consensus price target of $39.29.
The stock price for Capricor Therapeutics (NASDAQ: CAPR) is $14.02 last updated December 24, 2024 at 12:58 PM EST.
There are no upcoming dividends for Capricor Therapeutics.
Capricor Therapeutics’s Q4 earnings are confirmed for Thursday, February 27, 2025.
There is no upcoming split for Capricor Therapeutics.
Capricor Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.